Abstract

Mitigating the global challenge of antimicrobial resistance (AMR) requires a multifaceted approach, with increasing attention directed toward environmental contributors such as pharmaceutical effluents. The unchecked discharge of active pharmaceutical ingredients (APIs) from manufacturing plants, healthcare facilities, and post-consumer waste into aquatic environments creates persistent antibiotic residues that exert selective pressure on microbial communities. This process facilitates the evolution and spread of resistant genes, posing a significant threat to public health and ecological integrity. This paper critically reviews adopted chemical and biological methods for controlling pharmaceutical effluents to mitigate AMR and examines their broader implications in environmental chemistry. Chemical treatment methods such as advanced oxidation processes (AOPs), ozonation, and chlorination have demonstrated high efficiency in degrading complex pharmaceutical compounds. However, these methods often generate toxic by-products and require high operational costs and energy input, raising concerns about sustainability and secondary pollution. On the other hand, biological methods—particularly activated sludge systems, constructed wetlands, and enzymatic treatments—offer eco-friendly alternatives capable of biodegrading pharmaceutical residues under controlled conditions. These systems leverage microbial metabolism and plant-microbe interactions to reduce pollutant load, although their effectiveness can be influenced by environmental factors and the chemical structure of target compounds. The global environmental chemistry implications of these approaches are profound. While chemical treatments may alter the speciation and mobility of pharmaceutical residues, biological methods influence nutrient cycling, microbial diversity, and ecological resilience. Understanding the environmental fate and transformation pathways of pharmaceuticals and their metabolites is crucial for evaluating treatment efficacy and minimizing unintended consequences. Furthermore, integrating these treatment strategies with regulatory frameworks and real-time monitoring tools can significantly enhance risk mitigation, especially in low- and middle-income countries where effluent management is often inadequate. In conclusion, effective pharmaceutical effluent control through tailored chemical and biological methods is pivotal to addressing AMR. A comprehensive approach that combines scientific innovation, environmental monitoring, and global policy alignment is essential to safeguard ecosystems and human health from the escalating threat of antibiotic resistance.